Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
08/2010
08/05/2010US20100196267 Humanized L243 Antibodies
08/05/2010US20100196266 Humanized Anti-HLA-DR Antibodies
08/05/2010US20100196265 Anti-egfr family antibodies, bispecific anti-egfr family antibodies and methods of use thereof
08/05/2010US20100196264 Use of somatostatin analogs in myocardial perfusion imaging
08/05/2010CA2750230A1 Compositions for radiolabeling diethylenetriaminepentaacetic acid (dtpa)-dextran
08/04/2010EP2213311A1 Competitive chemiluminescent assay for cyclic nucleotide monophosphates
08/04/2010EP2212319A1 Labeled iodinated tropane formulation
08/04/2010EP2211913A2 Systemic administration of chlorotoxin agents for the diagnosis and treatment of tumors
08/04/2010EP2211912A1 Method of radiolabelling carbon nanotubes, radiolabelled carbon nanotubes, and applications thereof
08/04/2010EP2211911A2 Methods for diagnosing and monitoring treatment of lewy body dementia by assessing dopamine transporter level
08/03/2010US7767796 N4 chelator conjugates
08/03/2010US7767194 Using cyanine dyes; in situ supplying to tumor cells
08/03/2010US7767193 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
07/2010
07/29/2010US20100189649 Monoclonal antibodies to activated erbb family members and methods of use
07/29/2010US20100189645 Metal chelators and methods of their use
07/29/2010US20100189644 Arginase inhibitors and methods of use
07/29/2010US20100189643 Drug delivery with stimulus responsive biopolymers
07/29/2010US20100189642 Radionuclides for medical use
07/29/2010US20100189641 Novel Strategies for Improved Cancer Vaccines
07/29/2010CA2750581A1 Pta089 protein
07/28/2010EP2209805A1 An antigen associated with rheumatoid arthritis
07/28/2010EP2209498A2 Treatment of proliferative disorders using antibodies to psma
07/28/2010EP2209497A2 Method of differentially diagnosing by spect different types of dementia
07/28/2010CN101790387A Radiopharmaceutical composition
07/28/2010CN101787077A Preparation of 131I-thyroid stimulating hormone (TSH) and application thereof
07/27/2010US7763719 Detecting tumor cells expressing TAG-72 using CC49 in which less than all six (three heavy chain and three light chain) Complementarity Determining Regions are present; host cells
07/27/2010US7763594 comprising synergistic hyaluronic acid and dermatan sulphate; improved joint mobility
07/27/2010US7763234 peptides drugs that are converted into its active form, by cleavage by angiotensin converting enzyme in vivo, for use in the treatment and diagnosis of congestive heart failure, cardiac arrhythmia and other diseases where fibrosis is prominent
07/27/2010US7762957 measuring pancreatic metabolism, characterized by the fact that the increase in 13CO2 in the exhaled breath is determined prior to and following the intravenous application of secretin as well as prior to and following the oral application of a 13C triglyceride
07/27/2010CA2287872C Immunogenic compositions to the cck-b/gastrin receptor and methods for the treatment of tumors
07/22/2010WO2010083107A1 Biocompatible microbubbles to deliver radioactive compounds to tumors, atherosclerotic plaques, joints and other targeted sites
07/22/2010WO2010082634A1 Compound retained in tumor
07/22/2010WO2010048144A3 Imaging and radiotherapy methods
07/22/2010WO2010030120A3 Fluorescent silica nanoparticle with radioactive tag and the detecting method of pet and fluorescent dual imaging using thereof
07/22/2010WO2009040377A3 Radiolabelled 1, 4 -dihydro-4 -oxo-quinoline 3-carboxylic acid derivatives for pet and spect imaging, and in-vitro detection of the gaba-a receptor
07/22/2010US20100183512 Use of cthrc1 in diagnosing cancer of liver
07/22/2010US20100183511 Small peptides specifically bind to colorectal cancers
07/22/2010US20100183510 EphB RECEPTOR-BINDING PEPTIDES
07/22/2010US20100183509 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof
07/22/2010US20100183508 Radioactive mixture and manufacturing method thereof
07/22/2010US20100183507 Tumor markers in ovarian cancer
07/22/2010US20100183506 Antigen associated with lung cancers and lymphomas
07/22/2010US20100183505 Immunoconjugate for human cd66 for the treatment of multiple myeloma and other haematological malignancies
07/22/2010US20100183504 Multimodal imaging probes for in vivo targeted and non-targeted imaging and therapeutics
07/22/2010US20100183503 Myocardial perfusion imaging methods and compositions
07/22/2010US20100183502 Stabilized Uncoated Particles of Reversed Liquid Crystalline Phase Materials
07/22/2010CA2749797A1 Compound having tumor-resident property
07/21/2010EP1677813B1 Angiogenic peptides and uses thereof
07/21/2010CN101784566A Cytotoxicity mediation of cells evidencing surface expression of cd9
07/21/2010CN101781259A Precursor compound of 18F marked tumor inhibitor Monastrol as well as preparation method and application
07/21/2010CN101780286A Chemotactic factor receptor CXCR4 non-peptide antagonist medicaments for radiodiagnosis and treatment
07/20/2010US7759502 Stilbene derivatives and their use for binding and imaging amyloid plaques
07/20/2010US7759311 Small peptides for the treatment of alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders
07/20/2010US7758852 OX40R binding agents
07/20/2010CA2468858C Breath test
07/15/2010WO2010079579A1 Halogen-substituted saccharide, method for producing same, reaction composition of same and device for producing same
07/15/2010WO2010079079A2 PDGF-Rβ BINDERS
07/15/2010WO2010058361A3 Method for the production of scaffolds for tissue engineering, comprising the use of an anchoring unit, and scaffold produced therewith
07/15/2010WO2009134405A3 Substrate based pet imaging agents
07/15/2010WO2008148001A3 Method of imaging localized infections
07/15/2010US20100178248 Use of phenyloxyaniline derivatives for imaging cardiovascular diseases
07/15/2010US20100178247 Ca-ix specific radiopharmaceuticals for the treatment and imaging of cancer
07/15/2010US20100178246 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting psma
07/15/2010US20100178245 Biocompatible Microbubbles to Deliver Radioactive Compounds to Tumors, Atherosclerotic Plaques, Joints and Other Targeted Sites
07/15/2010US20100178244 Biocompatible Microbubbles to Deliver Radioactive Compounds to Tumors, Atherosclerotic Plaques, Joints and Other Targeted Sites
07/15/2010US20100178243 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system
07/15/2010US20100178242 Labelling methods
07/14/2010EP1824830B1 Radiolabelled quinoline-based ligands for the 5-ht6 receptor functionality
07/14/2010CN101775039A Preparation method and application of 99mTc-marked hydrazino nicotinamide-folate coordination compound
07/14/2010CN101775038A Marked cyclofenil derivative and referential compound and midbody thereof, and preparation method and application
07/14/2010CN101774961A Compound having affinity with progeria dementia A beta plaques, preparation method and application thereof
07/14/2010CN101773677A In vivo tumor imaging target molecule and specific probe thereof
07/13/2010US7754189 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
07/13/2010US7754188 Antagonists and/or inverse agonists of the Cannabinoid-1 receptor; useful in treatment of central nervous system disorders, psychological disorders, multiple sclerosis, as antiinflammatory agents
07/13/2010CA2522148C Thorium-227 for use in radiotherapy of soft tissue disease
07/13/2010CA2345932C Peptide-based carrier devices for stellate cells
07/08/2010WO2010078370A1 Synthesis of 18f-radiolabeled styrylpyridines from tosylate precursors and stable pharmaceutical compositions thereof
07/08/2010WO2010076654A2 CYSTEINE-FREE EFFICIENT TECHNETIUM (Tc) OR RHENIUM (Re) CHELATING PEPTIDE TAGS AND THEIR USE
07/08/2010WO2009114776A3 Integrin targeting agents and in-vivo and in-vitro imaging methods using the same
07/08/2010WO2009040727A3 Method of differentially diagnosing by spect different types of dementia
07/08/2010US20100172836 Synthesis of 18f-radiolabeled styrylpyridines from tosylate precursors and stable pharmaceutical compositions thereof
07/08/2010US20100172835 Methods and compositions for synaphically-targeted treatment for cancer
07/08/2010US20100172834 Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry
07/08/2010US20100172833 Methods and compositions for diagnosing hepatocellular carcinoma
07/08/2010US20100172832 Diagnosis and treatment of malignant neoplasms
07/08/2010US20100172831 Protein-Modified Nano-Droplets, Compositions and Methods of Production
07/08/2010US20100172830 Extraembryonic Tissue cells and method of use thereof
07/08/2010US20100172829 Enhanced carriers for the delivery of microparticles to bodily tissues and fluids
07/08/2010CA2748705A1 Synthesis of 18f-radiolabeled styrylpyridines from tosylate precursors and stable pharmaceutical compositions thereof
07/08/2010CA2745946A1 Cysteine-free efficient technetium (tc) or rhenium (re) chelating peptide tags and their use
07/07/2010EP2204377A1 Cysteine-free technetium (tc) or rhenium (re) chelating peptide tags and their use
07/07/2010EP1560601B1 Stabilization of aqueous compositions of 18f-isotope labelled 2-fluoro-2-deoxy-d-glucose with ethanol
07/07/2010EP1079862B1 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody
07/07/2010CN1972720B Alpha-emitting hydroxyapatite particles
07/07/2010CN101768208A Novel 18F-labelled polypeptide, preparation method and application thereof in tumor imaging
07/06/2010US7749718 Method for raising or isolating an antibody to DCRS5
07/06/2010US7749520 cationic liposomes containing alpha, alpha'-trehalose 6,6' dibehenate, ceramide and ganglioside, prepared from bromide salt of dimethyldioctadeceylammonium; drug delivery; immunology, vaccines
07/06/2010US7749485 Liposomal assembly for therapeutic and/or diagnostic use
07/01/2010WO2010074326A1 Probe for a biological specimen and labelling method and screening method using the probe
07/01/2010WO2010074272A1 Method for rapidly methylating heteroaromatic ring aryl and method for producing pet tracer
1 ... 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 ... 243